News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
528,774 Results
Type
Article (13299)
Company Profile (150)
Press Release (515235)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (179162)
Career Advice (480)
Deals (27314)
Drug Delivery (14)
Drug Development (56257)
Employer Resources (24)
FDA (10968)
Job Trends (9669)
News (256410)
Policy (20446)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1052)
Academic (1)
Accelerated approval (27)
ADA (19)
Adcomms (1)
Allergies (104)
Alliances (37032)
ALS (114)
Alzheimer's disease (1108)
Antibody-drug conjugate (ADC) (297)
Approvals (11632)
Artificial intelligence (383)
ASCO (181)
Autoimmune disease (218)
Automation (53)
Bankruptcy (274)
Best Places to Work (7588)
BIO (37)
BIOSECURE Act (2)
Biosimilars (115)
BioSpace Insights (24)
Biotechnology (96)
Bladder cancer (164)
Brain cancer (30)
Breast cancer (568)
Cancer (4083)
Cardiovascular disease (242)
Career advice (409)
Career pathing (3)
CAR-T (195)
CDC (6)
Celiac Disease (2)
Cell therapy (532)
Cervical cancer (41)
Clinical research (50361)
Collaboration (1454)
Commercialization (3)
Company closure (1)
Compensation (1451)
Complete response letters (35)
COVID-19 (1167)
CRISPR (73)
C-suite (816)
Cystic fibrosis (97)
Data (6018)
Denatured (5)
Depression (104)
Dermatology (63)
Diabetes (370)
Diagnostics (5770)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (200)
Drug pricing (11)
Drug shortages (5)
Duchenne muscular dystrophy (176)
Earnings (76061)
Editorial (2)
Employer branding (5)
Employer resources (23)
Events (91870)
Executive appointments (768)
FDA (13797)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1030)
Gene editing (139)
Generative AI (15)
Gene therapy (369)
GLP-1 (384)
Government (1636)
Grass and pollen (3)
Guidances (300)
Healthcare (10525)
Hematology (109)
HIV (59)
Huntington's disease (22)
IgA nephropathy (66)
Immunology and inflammation (106)
Immuno-oncology (60)
Indications (171)
Infectious disease (1391)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (99)
Intellectual property (262)
Interviews (63)
IPO (12885)
IRA (3)
Job creations (2441)
Job search strategy (390)
JPM (6)
Kidney cancer (17)
Labor market (4)
Layoffs (94)
Leadership (3)
Legal (5540)
Licensing (7)
Liver cancer (52)
Longevity (19)
Lung cancer (550)
Lymphoma (290)
Machine learning (32)
Management (7)
Manufacturing (637)
Marketing (8)
MASH (123)
Medical device (9402)
Medtech (9546)
Mergers & acquisitions (15520)
Metabolic disorders (756)
mRNA (66)
Multiple sclerosis (107)
NASH (5)
Neurodegenerative disease (243)
Neuropsychiatric disorders (40)
Neuroscience (2018)
NextGen: Class of 2026 (3573)
Non-profit (1326)
Now hiring (17)
Obesity (239)
Opinion (35)
Ovarian cancer (176)
Pain (176)
Pancreatic cancer (212)
Parkinson's disease (227)
Partnered (20)
Patents (485)
Patient recruitment (519)
Peanut (36)
People (44664)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase 1 (16220)
Phase 2 (22288)
Phase 3 (15380)
Pipeline (7765)
Policy (25)
Postmarket research (1745)
Preclinical (7024)
Press Release (42)
Prostate cancer (215)
Psychedelics (7)
Radiopharmaceuticals (208)
Rare diseases (613)
Real estate (4117)
Recruiting (9)
Regulatory (16677)
Reports (21)
Research institute (1095)
Resumes & cover letters (60)
Rett syndrome (42)
RNA editing (5)
RSV (51)
Schizophrenia (101)
Series A (172)
Series B (128)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (95)
Sponsored (11)
Startups (2332)
State (1)
Stomach cancer (4)
Supply chain (63)
Tariffs (1)
The Weekly (1)
Vaccines (382)
Venture capital (18)
Weight loss (87)
Women's health (87)
Worklife (1)
Date
Last 7 days (482)
Last 30 days (1678)
Last 365 days (20374)
2026 (12967)
2025 (20491)
2024 (24651)
2023 (28609)
2022 (37423)
2021 (40343)
2020 (37154)
2019 (26391)
2018 (19847)
2017 (21247)
2016 (20538)
2015 (26686)
2014 (23736)
2013 (20164)
2012 (22159)
2011 (22416)
2010 (21883)
Location
Africa (331)
Alabama (79)
Alaska (4)
Arizona (318)
Arkansas (11)
Asia (21602)
Australia (2892)
California (12290)
Canada (3256)
China (592)
Colorado (503)
Connecticut (424)
Delaware (243)
Europe (35146)
Florida (1822)
Georgia (384)
Hawaii (3)
Idaho (47)
Illinois (753)
India (58)
Indiana (378)
Iowa (15)
Japan (417)
Kansas (113)
Kentucky (39)
Louisiana (33)
Maine (35)
Maryland (1315)
Massachusetts (8167)
Michigan (317)
Minnesota (599)
Mississippi (4)
Missouri (134)
Montana (27)
Nebraska (12)
Nevada (123)
New Hampshire (65)
New Jersey (2853)
New Mexico (18)
New York (2929)
North Carolina (1407)
North Dakota (4)
Northern California (6112)
Ohio (338)
Oklahoma (14)
Oregon (19)
Pennsylvania (2325)
Puerto Rico (22)
Rhode Island (35)
South America (541)
South Carolina (78)
South Dakota (1)
Southern California (5120)
Tennessee (139)
Texas (1999)
United States (40712)
Utah (379)
Vermont (1)
Virginia (167)
Washington D.C. (42)
Washington State (984)
West Virginia (1)
Wisconsin (90)
528,774 Results for "alcon laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
July 7, 2026
·
4 min read
Press Releases
Alcon Announces Results of 2026 Annual General Meeting
May 1, 2026
·
2 min read
Press Releases
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
June 29, 2026
·
3 min read
Press Releases
LENSAR® Provides Update on Pending Acquisition by Alcon
February 26, 2026
·
4 min read
Press Releases
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
March 16, 2026
·
5 min read
Mergers & acquisitions
Alcon Secures Majority Stake in Aurion, Deposes CEO
Last month, Deerfield Management accused Alcon of obstructing Aurion’s IPO plans so it could acquire the startup “at a discount.”
March 27, 2025
·
1 min read
·
Tristan Manalac
IPO
‘Valentine’s Day Massacre’: Deerfield Claims Alcon is Blocking Aurion’s IPO
Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
Press Releases
Alcon Agrees to Acquire STAAR Surgical
August 5, 2025
·
12 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
1 of 52,878
Next
